China is currently in the news for launching a new high-speed railway line that links over 50 scenic tourist spots in the Yangtze River Delta. Having 10 stations, the new railway line extends up to 265km, where trains travel at a speed of 250kmh. According …
Infratil has reportedly announced that it plans to sell its New Zealand bus transport business to Next Capital, an Australian private equity firm. Post the transaction closure, the New Zealand firm Infratil expects to receive between $218 million and $240 million from the sale. A …
By signing a collaboration deal with Agenus, Gilead is continuing to foray into the field of cancer immunotherapy. The partnership aims to develop & commercialize around five new immuno-oncology (I-O) treatments. Gilead Sciences, Inc., (Gilead), a renowned American biotechnology company, has reportedly announced that it …
AVANT Communications, a leading next generation IT solutions-provider, has reportedly inked a partnership agreement with Logicworks, a top cloud service provider, in a bid to deliver the agent channel community cloud migration, optimization and operations services. Sources familiar with the matter claim that the master …
Glenmark’s branded portfolio will be developed and commercialized under the subsidiary Glenmark Therapeutics Inc., USA. Renowned pharmaceutical firm, Glenmark Pharmaceuticals has recently announced that its wholly owned subsidiary, Glenmark Therapeutics Inc., USA, will enter the branded dermatology segment in the United States. This will be …
Cannabis firms Aleafia Health Inc. and Emblem Corp. have recently announced that they have inked a definitive agreement according to which, Aleafia would acquire all of the issued and common shares of Emblem in an all-share transaction. The deal, to proceed as per a plan …
The acquisition will help Merck gain access to a broader customer base and enhance its Animal Health segment Renowned pharmaceutical company, Merck & Co., Inc., has recently announced that it has reached a definitive agreement to acquire all unresolved shares of French animal health firm, …
Graphcore, a semiconductor company based in Bristol, that develops accelerators for AI and machine learning, has reportedly declared the closure of a $200 million Series D round. Sources claim that the round was jointly led by investors European Venture Captial Atomico and Sofina, an investment …